BGHL (GBP): NAV(s)
September 14, 2018 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
BGHL (EUR): NAV(s)
September 14, 2018 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Amendment of Facilities Agreement
September 14, 2018 01:01 ET
|
ARYZTA AG
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE...
Amendment of Facilities Agreement
September 14, 2018 01:00 ET
|
ARYZTA AG
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
NOT FOR DISTRIBUTION OR...
Start of Day Message
September 14, 2018 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 14 Sep. 2018 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Nasdaq Corporate Solutions and is designated by the FCA as an approved...
ACACIA PHARMA ANNOUNCES POSITIVE BARHEMSYS(TM) DATA PUBLISHED IN LEADING ANAESTHESIA JOURNAL
September 14, 2018 01:00 ET
|
Acacia Pharma Group plc
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Phase 3 Clinical Trial Data Show...
Innate Pharma reports first half 2018 financial results and business update
September 14, 2018 01:00 ET
|
INNATE PHARMA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
InNate Pharma REports first Half 2018...
Bone Therapeutics SA announces final results from Phase I/IIA ALLOB delayed-union fracture study
September 14, 2018 01:00 ET
|
Bone Therapeutics SA
Regulated information All patients met primary endpoint Optimized production process delivering critical improvements for future commercial use to be applied to all allogeneic platform...
Unaudited consolidated financial information of Žemaitijos pienas, AB for the first half of the year 2018 ended 30 June 2018.
September 14, 2018 00:50 ET
|
Zemaitijos Pienas
Žemaitijos pienas, AB presents its unaudited consolidated financial information for the first half of 2018. LawyerGintaras Keliauskas+ 370 444 22208
Attachments
...
Principia Biopharma Announces Pricing of Initial Public Offering
September 13, 2018 22:49 ET
|
Principia Biopharma Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Principia or the Company, Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing...
- May 18, 2024 17:16 ET MenuSifu announces restaurant automation partnership with Happy Cashier and Hestia at NRA 2024
- May 18, 2024 10:18 ET Credit Card Compare Announces Credit Card Product Data API Tool